NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City SHELTON, Conn., May 04, 2023 (GLOBE NEWSWIRE) -- (via IBN) -- NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), a clinical stage global leader in the development of highly effective...

President and Chairman of the Board of Directors, Anil R. Diwan, Ph.D., of NanoViricides, Inc., Discusses Company Updates with Everett Jolly on Uptick Newswire’s “Stock Day” Podcast PHOENIX, Aug. 21, 2018 (GLOBE NEWSWIRE) -- NanoViricides, Inc. (NYSE:NNVC), (the “Company”) announced President and Chairman, Dr. Anil Diwan’s interview on Uptick Newswire’s “Stock Day” Podcast. ...

NanoViricides Presents at the Premiere Event of the Year for Connecticut's Technology Leaders NEW YORK, Sept. 28, 2005 (PRIMEZONE) -- NanoViricides, Inc. (Pink Sheets:NNVC) announced that its President, Dr. Anil Diwan, has been selected to present today to a group of select investors at the...

NanoViricides Announces Progress in Development of FluCide-I Influenza Drug NEW YORK, Sept. 20, 2005 (PRIMEZONE) -- NanoViricides, Inc. (Pink Sheets:NNVC) announced today that the Company is actively developing its first NanoViricide(tm) drug, "FluCide-I(tm)." The Company...